Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
N4 Pharma Plc |
4/02 | 0,625 GBX
-7,41% |
-7,41% |
Nanalysis Scientific Corp. |
4/02 | 0,300 CAD
-1,64% |
-1,64% |
Nano X Imaging Ltd |
4/02 | 7,230 USD
+2,12% |
+2,12% |
|
Nanobiotix |
4/02 | 3,460 USD
-0,86% |
-0,86% |
Nanobiotix |
4/02 | 3,400 EUR
+0,24% |
+0,24% |
NanoRepro AG |
4/02 | 1,355 EUR
-1,09% |
-1,09% |
|
Nanostring Technologies Inc |
16/01 | 0,105 USD
0,00% |
0,00% |
|
NanoVibronix Inc |
4/02 | 0,481 USD
-8,01% |
-8,01% |
|
NanoViricides Inc |
4/02 | 1,140 USD
-2,56% |
-2,56% |
|
Natera Inc |
4/02 | 174,240 USD
-1,31% |
-1,31% |
|
Natural Alternatives International, Inc. |
4/02 | 4,150 USD
-1,89% |
-1,89% |
|
Navidea Biopharmaceuticals Inc |
31/01 | 0,001 USD
+900,00% |
+900,00% |
|
Nektar Therapeutics |
4/02 | 0,779 USD
-3,72% |
-3,72% |
|
Nemaura Medical Inc |
30/01 | 0,000 USD
0,00% |
0,00% |
|
Neogen Corp. |
4/02 | 10,640 USD
-2,74% |
-2,74% |
|
Neovacs |
3/02 | 0,300 EUR
+15,35% |
+15,35% |
|
Nephros Inc |
4/02 | 1,580 USD
-0,28% |
-0,28% |
|
NervGen Pharma Corp |
4/02 | 2,930 CAD
0,00% |
0,00% |
|
Neurocrine Biosciences, Inc. |
4/02 | 152,420 USD
+1,55% |
+1,55% |
|
Neurometrix Inc. |
4/02 | 4,381 USD
+1,41% |
+1,41% |
|
Neuronetics Inc |
4/02 | 3,450 USD
+7,81% |
+7,81% |
|
Nevro Corp |
4/02 | 5,130 USD
+3,01% |
+3,01% |
|
Nextcure Inc |
4/02 | 0,784 USD
+1,51% |
+1,51% |
|
NIOX Group Plc
|
4/02 | 60,000 GBX
+2,04% |
+2,04% |
|
Nkarta Inc |
4/02 | 2,260 USD
+4,15% |
+4,15% |
|
NLS Pharmaceutics Ltd |
4/02 | 2,000 USD
-7,83% |
-7,83% |
|
Novabay Pharmaceuticals Inc |
4/02 | 0,637 USD
-3,48% |
-3,48% |
|
Novacyt |
4/02 | 0,620 EUR
-0,64% |
-0,64% |
Novartis AG |
4/02 | 95,590 CHF
-0,52% |
-0,52% |
|
Novartis AG |
4/02 | 105,470 USD
-0,01% |
-0,01% |
|
Novavax, Inc. |
4/02 | 8,435 USD
+0,06% |
+0,06% |
|
Novo Nordisk A/S |
4/02 | 82,620 USD
-0,04% |
-0,04% |
Novo Nordisk A/S |
4/02 | 592,600 DKK
-1,18% |
-1,18% |
|
NovoCure Ltd |
4/02 | 23,670 USD
-0,34% |
-0,34% |
|
NuCana plc |
4/02 | 1,030 USD
+6,19% |
+6,19% |
|
Nuformix plc |
4/02 | 0,075 GBX
+2,74% |
+2,74% |
|
Nurix Therapeutics Inc |
4/02 | 18,590 USD
-1,90% |
-1,90% |
|
Nutriband Inc |
4/02 | 7,780 USD
+5,71% |
+5,71% |
Nyxoah |
4/02 | 10,300 EUR
-2,83% |
-2,83% |